Crossmark

Effect of Alzheimer’s disease medications on neurocognitive outcomes in children and adolescents with autism spectrum disorder and low IQ: a scoping review

Crossref DOI link: https://doi.org/10.1038/s41398-025-03655-2

Published Online: 2025-11-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Diamandis, Nicholas

van den Anker, John N.

Denisova, Kristina https://orcid.org/0000-0002-0104-019X
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH121605)

Simons Foundation (614242)
License Information

Text and Data Mining valid from 2025-11-17

Version of Record valid from 2025-11-17
More Information

Article History

Received: 6 November 2023

Revised: 27 August 2025

Accepted: 2 October 2025

First Online: 17 November 2025

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below